Description
Lorbriqua 25mg Tablet is used to treat adults with unresectable (unremovable), advanced, or recurrent forms of non-small cell lung cancer (NSCLC). It works by inhibiting an enzyme called anaplastic lymphoma kinase (ALK) and is given to patients who have an alteration in this enzyme.
Additional information
| Brand | Lorbriqua |
|---|---|
| Generic name | Lorlatinib tablets |
| Form | Oral tablet |
| Strength | 25mg |
| Packing | 3*10 tablets |
| Manufacturer | Pfizer |
| Documents | Either PO or prescription |
| Storage | 20-25°C temperature |
Reviews
There are no reviews yet.